A 75 year of old hypertensive lady has a 2 x 2 cm infiltrating duct cell carcinoma in the subareolar region. There are not palpable lymph nodes and distant metastases. However, she had been treated for pulmonary tuberculosis 20 years ago. The best course of management would be-
**Core Concept**
The management of breast cancer in a patient with a history of pulmonary tuberculosis (TB) requires careful consideration of the patient's past medical history and the potential impact of immunosuppression on cancer treatment and prognosis. The patient's age, hypertension, and history of TB are relevant factors in determining the best course of management.
**Why the Correct Answer is Right**
The correct answer is mastectomy with axillary lymph node dissection (ALND). This is because the patient has a relatively large tumor (2 x 2 cm) and a history of TB, which may have immunocompromised her. Infiltrating ductal carcinoma is a common type of breast cancer, and a subareolar location is not uncommon. The absence of palpable lymph nodes and distant metastases suggests that the cancer is still localized, making surgical management a viable option. The patient's age and hypertension are also relevant factors to consider, but they do not alter the fundamental approach to managing her breast cancer.
**Why Each Wrong Option is Incorrect**
**Option A:** Radiation therapy alone is not sufficient for a 2 x 2 cm infiltrating ductal carcinoma, especially in a patient with a history of TB, which may have compromised her immune system.
**Option B:** Hormone receptor status is not provided, and breast cancer treatment should not be delayed or altered based on a patient's age or hypertension alone.
**Option C:** Neoadjuvant chemotherapy may be considered in some cases, but it is not the best initial approach for a patient with a localized tumor and no evidence of distant metastases.
**Clinical Pearl / High-Yield Fact**
In patients with a history of immunosuppression or chronic diseases, such as pulmonary TB, it is essential to consider the potential impact on cancer treatment and prognosis. This may involve more aggressive treatment or closer monitoring to ensure the best possible outcomes.
**Correct Answer: C. Neoadjuvant chemotherapy followed by mastectomy with ALND.**